NASDAQ: MCRB Seres Therapeutics, Inc. 8-K

Seres Therapeutics schedules 2026 annual meeting for June 9, sets stockholder proposal deadline

Filed March 16, 2026 · Period ending March 16, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MCRB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 5, 2026 12:15 AM